Literature DB >> 12221002

Developmental expression and biochemical characterization of Emu family members.

Cornelia Leimeister1, Christian Steidl, Nina Schumacher, Sabine Erhard, Manfred Gessler.   

Abstract

Kidney development has often served as a model for epithelial-mesenchymal cell interaction where the branching epithelium of the ureteric bud induces the metanephrogenic mesenchyme to form epithelial nephrons. In a screen for genes differentially expressed during kidney development, we have identified a novel gene that is dynamically expressed in the branching ureter and the developing nephrons. It was designated Emu1 since it shares an N-terminal cysteine-rich domain with Emilin1/2 and Multimerin. This highly conserved EMI domain is also found in another novel protein (Emu2) of similar protein structure: an N-terminal signal peptide followed by the EMI domain, an interrupted collagen stretch, and a conserved C-terminal domain of unknown function. We identified two further secreted EMI domain proteins, prompting us to compare their gene and protein structures, the EMI domain phylogeny, as well as the embryonic expression pattern of known (Emilin1/2, Multimerin) and novel (Emu1/2, Emilin3, Multimerin2) Emu gene family members. Emu1 and Emu2 not only show a similar structural organization, but furthermore a striking complementary expression in organs developing through epithelial-mesenchymal interactions. In these tissues, Emu1 is restricted to epithelial and Emu2 to mesenchymal cells. Preliminary biochemical analysis of Emu1/2 confirmed that they are secreted glycoproteins which are attached to the extracellular matrix and capable of forming homo- and heteromers via disulfide bonding. The widespread, but individually distinct expression patterns of all Emu gene family members suggest multiple functions during mouse embryogenesis. Their multidomain protein structure may indicate that Emu proteins interact with several different extracellular matrix components and serve to connect and integrate the function of multiple partner molecules.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221002     DOI: 10.1006/dbio.2002.0764

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  21 in total

1.  EMILIN-1 deficiency induces elastogenesis and vascular cell defects.

Authors:  Miriam Zanetti; Paola Braghetta; Patrizia Sabatelli; Isabella Mura; Roberto Doliana; Alfonso Colombatti; Dino Volpin; Paolo Bonaldo; Giorgio M Bressan
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

2.  EMILIN-3, peculiar member of elastin microfibril interface-located protein (EMILIN) family, has distinct expression pattern, forms oligomeric assemblies, and serves as transforming growth factor β (TGF-β) antagonist.

Authors:  Alvise Schiavinato; Ann-Kathrin A Becker; Miriam Zanetti; Diana Corallo; Martina Milanetto; Dario Bizzotto; Giorgio Bressan; Marija Guljelmovic; Mats Paulsson; Raimund Wagener; Paola Braghetta; Paolo Bonaldo
Journal:  J Biol Chem       Date:  2012-02-10       Impact factor: 5.157

Review 3.  Collagenous Extracellular Matrix Biomaterials for Tissue Engineering: Lessons from the Common Sea Urchin Tissue.

Authors:  Kheng Lim Goh; David F Holmes
Journal:  Int J Mol Sci       Date:  2017-04-25       Impact factor: 5.923

4.  The crucial role of emilin 1 gene expression during progression of tumor growth.

Authors:  Miroslava Rabajdova; Peter Urban; Ivana Spakova; Ladislav Saksun; Rastislav Dudic; Alexander Ostro; Martin Caprnda; Peter Kruzliak; Mariusz Adamek; Maria Marekova
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-31       Impact factor: 4.553

5.  Characterization of C1q in teleosts: insight into the molecular and functional evolution of C1q family and classical pathway.

Authors:  Yu-Lan Hu; Xin-Min Pan; Li-Xin Xiang; Jian-Zhong Shao
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

6.  A possible association of EMID2 polymorphisms with aspirin hypersensitivity in asthma.

Authors:  Charisse Flerida A Pasaje; Jeong-Hyun Kim; Byung-Lae Park; Hyun Sub Cheong; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Chein-Soo Hong; Yong Won Lee; Jae-Young Lee; In Song Koh; Tae-Joon Park; Jin-Sol Lee; Yongha Kim; Joon Seol Bae; Choon-Sik Park; Hyoung Doo Shin
Journal:  Immunogenetics       Date:  2010-11-18       Impact factor: 2.846

7.  Unexpected rescue of alpha-synuclein and multimerin1 deletion in C57BL/6JOlaHsd mice by beta-adducin knockout.

Authors:  Srećko Gajović; Dinko Mitrecić; Lana Augustincić; Alessandra Iaconcig; Andrés F Muro
Journal:  Transgenic Res       Date:  2006-04       Impact factor: 2.788

8.  Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease.

Authors:  Kenya Nishioka; Christian Wider; Carles Vilariño-Güell; Alexandra I Soto-Ortolaza; Sarah J Lincoln; Jennifer M Kachergus; Barbara Jasinska-Myga; Owen A Ross; Alex Rajput; Christopher A Robinson; Tanis J Ferman; Zbigniew K Wszolek; Dennis W Dickson; Matthew J Farrer
Journal:  Arch Neurol       Date:  2010-08

9.  Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.

Authors:  Sandy R Larson; Xiaotun Zhang; Ruth Dumpit; Ilsa Coleman; Bryce Lakely; Martine Roudier; Celestia S Higano; Lawrence D True; Paul H Lange; Bruce Montgomery; Eva Corey; Peter S Nelson; Robert L Vessella; Colm Morrissey
Journal:  Prostate       Date:  2013-01-17       Impact factor: 4.104

10.  Regeneration enhanced in critical-sized bone defects using bone-specific extracellular matrix protein.

Authors:  Solaleh Miar; Joseph Pearson; Sergio Montelongo; Rogelio Zamilpa; Alejandro M Betancourt; Bharath Ram; Christopher Navara; Mark R Appleford; Joo L Ong; Sy Griffey; Teja Guda
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2020-09-11       Impact factor: 3.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.